Sulin L. Zhang

State Key Laboratory Of Drug Research
Shanghai, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 80 publications

Analysis of the prevalence rate and risk factors of gallstone in the elderly in Xuhui District of Shanghai

Analysis of the prevalence rate and risk factors of gallstone in the elderly in Xuhui District of Shanghai

Journal: Zhonghua wai ke za zhi [Chinese journal of surgery]

Published: August 30, 2026

Mapping Non-Homologous Pocket Compatibilities to Identify Hidden Drug-Target Relationships: A Pocket Hopping Framework.

Mapping Non-Homologous Pocket Compatibilities to Identify Hidden Drug-Target Relationships: A Pocket Hopping Framework.

Journal: Journal of medicinal chemistry

Published: July 18, 2026

Development of potent and selective ENPP1 inhibitors based on imidazo[1,2-a]pyrazine and pyrazine scaffolds for cancer immunotherapy.

Development of potent and selective ENPP1 inhibitors based on imidazo[1,2-a]pyrazine and pyrazine scaffolds for cancer immunotherapy.

Journal: European journal of medicinal chemistry

Published: June 29, 2026

Virtual screening, synthesis and activity evaluation of quinoline derivatives as potential stabilizers of p53 Y220C.

Virtual screening, synthesis and activity evaluation of quinoline derivatives as potential stabilizers of p53 Y220C.

Journal: Computational biology and chemistry

Published: June 09, 2026

Structure-Guided Discovery of Potent, Selective, and Orally Bioavailable Werner Syndrome RecQ Helicase Inhibitors for the Treatment of Microsatellite Instability-High Tumors.

Structure-Guided Discovery of Potent, Selective, and Orally Bioavailable Werner Syndrome RecQ Helicase Inhibitors for the Treatment of Microsatellite Instability-High Tumors.

Journal: Journal of medicinal chemistry

Published: June 03, 2026

Targeting RBPMS selectively eliminates FOXO1-mediated stem cell signatures in mouse models of acute myeloid leukemia.

Targeting RBPMS selectively eliminates FOXO1-mediated stem cell signatures in mouse models of acute myeloid leukemia.

Journal: Science translational medicine

Published: May 06, 2026

Construction of PROTAC Library via Liquid-Phase Synthesis Enabled by a Hydrophobic Tag.

Construction of PROTAC Library via Liquid-Phase Synthesis Enabled by a Hydrophobic Tag.

Journal: Organic letters

Published: February 12, 2026

Targeting the FOXP3-T-bet interaction to restore Treg stability in IFN-γ-driven autoimmunity.

Targeting the FOXP3-T-bet interaction to restore Treg stability in IFN-γ-driven autoimmunity.

Journal: Cellular & molecular immunology

Published: February 01, 2026

Flexible protein-ligand docking with diffusion-based side-chain packing.

Flexible protein-ligand docking with diffusion-based side-chain packing.

Journal: Proceedings of the National Academy of Sciences of the United States of America

Published: December 24, 2025

Furo[2,3-f]quinazolin-7(6H)-one Derivatives as Potent, Selective, and Orally Bioavailable MAT2A Inhibitors for MTAP-Deficient Cancer Therapy.

Furo[2,3-f]quinazolin-7(6H)-one Derivatives as Potent, Selective, and Orally Bioavailable MAT2A Inhibitors for MTAP-Deficient Cancer Therapy.

Journal: Journal of medicinal chemistry

Published: November 17, 2025

Discovery of novel covalent agonists for p53 Y220C through synergistic strategy combining covalent binding and scaffold hopping.

Discovery of novel covalent agonists for p53 Y220C through synergistic strategy combining covalent binding and scaffold hopping.

Journal: European journal of medicinal chemistry

Published: November 05, 2025

Editorial: Advancing drug discovery with AI: drug-target interactions, mechanisms of action, and screening.

Editorial: Advancing drug discovery with AI: drug-target interactions, mechanisms of action, and screening.

Journal: Frontiers in pharmacology

Published: October 09, 2025

Showing 1-12 of 80

Last Updated: 09/26/2026